A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome

FEMS Microbiology Ecology

Volumn 87, Issue 2, 2014, Pages 357-367

  Xiao, Shuiming ^a   Fei, Na ^a   Pang, Xiaoyan ^a   Shen, Jian ^b   Wang, Linghua ^a   Zhang, Baorang ^a   Zhang, Menghui ^a   Zhang, Xiaojun ^a   Zhang, Chenhong ^a   Li, Min ^a   Sun, Lifeng ^a   Xue, Zhengsheng ^a   Wang, Jingjing ^a   Feng, Jie ^a   Yan, Feiyan ^a   Zhao, Naisi ^a   Liu, Jiaqi ^a   Long, Wenmin ^a   Zhao, Liping ^a,b  

^a Shanghai Jiao Tong University   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Chronic inflammation; Dietary intervention; Gut microbiota; Metabolic syndrome

Indexed keywords

ACUTE PHASE PROTEIN; BACTERIAL DNA; CARRIER PROTEIN; LACTULOSE; LIPOPOLYSACCHARIDE BINDING PROTEIN; LIPOPOLYSACCHARIDE-BINDING PROTEIN; MANNITOL; MEMBRANE PROTEIN;

ARTICLE; BLOOD; CHRONIC INFLAMMATION; CLINICAL TRIAL; DIET THERAPY; DIETARY INTERVENTION; FECES; FEMALE; GASTROINTESTINAL TRACT; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INTESTINE; INTESTINE FLORA; MALE; METABOLIC SYNDROME X; METABOLISM; MICROBIOLOGY; MICROFLORA; OBESITY;

CHRONIC INFLAMMATION; DIETARY INTERVENTION; GUT MICROBIOTA; METABOLIC SYNDROME;

ACUTE-PHASE PROTEINS; BLOOD GLUCOSE; CARRIER PROTEINS; DNA, BACTERIAL; FECES; FEMALE; GASTROINTESTINAL TRACT; HUMANS; INFLAMMATION; INSULIN RESISTANCE; INTESTINES; LACTULOSE; MALE; MANNITOL; MEMBRANE GLYCOPROTEINS; METABOLIC SYNDROME X; MICROBIOTA; OBESITY;

EID: 84895077527     PISSN: 01686496     EISSN: 15746941     Source Type: Journal    
DOI: 10.1111/1574-6941.12228     Document Type: Article

References (41)

1. Alvarez JA, Higgins PB, Oster RA, Fernandez JR, Darnell BE & Gower BA (2009) Fasting and postprandial markers of inflammation in lean and overweight children. Am J Clin Nutr 89: 1138-1144.
2. Bulló M, Casas-Agustench P, Amigó-Correig P, Aranceta J & Salas-Salvadó J (2007) Inflammation, obesity and comorbidities: the role of diet. Public Health Nutr 10: 1164-1172.
3. Cani PD, Amar J, Iglesias MA et al. (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56: 1761-1772.
4. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM & Burcelin R (2008) Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57: 1470-1481.
5. Dandona P, Weinstock R, Thusu K, Abdel-Rahman E, Aljada A & Wadden T (1998) Tumor necrosis factor-α in sera of obese patients: fall with weight loss. J Clin Endocr Metab 83: 2907-2910.
6. Diamant M, Blaak EE & de Vos WM (2011) Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes? Obes Rev 12: 272-281.
7. Dietrich M & Jialal I (2005) The effect of weight loss on a stable biomarker of inflammation, C-reactive protein. Nutr Rev 63: 22-28.
8. Duncan SH, Lobley GE, Holtrop G, Ince J, Johnstone AM, Louis P & Flint HJ (2008) Human colonic microbiota associated with diet, obesity and weight loss. Int J Obes 32: 1720-1724.
9. Fei N & Zhao L (2013) An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice. ISME J 7: 880-884.
10. Furet J-P, Kong L-C, Tap J, Poitou C, Basdevant A, Bouillot J-L, Mariat D, Corthier G, Doré J & Henegar C (2010) Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss links with metabolic and low-grade inflammation markers. Diabetes 59: 3049-3057.
11. Giugliano D, Ceriello A & Esposito K (2008) Are there specific treatments for the metabolic syndrome? Am J Clin Nutr 87: 8-11.
12. Goldstein DJ (1992) Beneficial health effects of modest weight loss. Int J Obes Relat Metab Disord 16: 397-415.
13. Griffiths EA, Duffy LC, Schanbacher FL, Qiao H, Dryja D, Leavens A, Rossman J, Rich G, Dirienzo D & Ogra PL (2004) In vivo effects of bifidobacteria and lactoferrin on gut endotoxin concentration and mucosal immunity in Balb/c mice. Dig Dis Sci 49: 579-589.
14. Guerra RA, Casafont F, Crespo J, Cayón A, Mayorga M, Estebanez A, Fernadez-Escalante JC & Pons-Romero F (2007) Lipopolysaccharide-binding protein plasma levels and liver TNF-alpha gene expression in obese patients: evidence for the potential role of endotoxin in the pathogenesis of non-alcoholic steatohepatitis. Obes Surg 17: 1374-1380.
15. Hakansson A & Molin G (2011) Gut microbiota and inflammation. Nutrients 3: 637-682.
16. Heilbronn LK, Noakes M & Clifton PM (2001) Energy restriction and weight loss on very-low-fat diets reduce C-reactive protein concentrations in obese, healthy women. Arterioscl Throm Vas 21: 968-970.
17. Heumann D (2001) CD14 and LBP in endotoxemia and infections caused by Gram-negative bacteria. J Endotoxin Res 7: 439-441.
18. Huse SM, Huber JA, Morrison HG, Sogin ML & MarkWelch D (2007) Accuracy and quality of massively parallel DNA pyrosequencing. Genome Biol 8: R143.
19. James WPT (2008) The epidemiology of obesity: the size of the problem. J Intern Med 263: 336-352.
20. Leiherer A, Mündlein A & Drexel H (2012) Phytochemicals and their impact on adipose tissue inflammation and diabetes. Vascul Pharmacol 58: 3-20.
21. Lepper P, Schumann C, Triantafilou K, Rasche F, Schuster T, Frank H, Schneider E, Triantafilou M & von Eynatten M (2007) Association of lipopolysaccharide-binding protein and coronary artery disease in men. J Am Coll Cardiol 50: 25-31.
22. Ley RE, Turnbaugh PJ, Klein S & Gordon JI (2006) Microbial ecology: human gut microbes associated with obesity. Nature 444: 1022-1023.
23. Lindberg AA, Weintraub A, Zähringer U & Rietschel ET (1990) Structure-activity relationships in lipopolysaccharides of Bacteroides fragilis. Rev Infect Dis 12: S133-S141.
24. Ludwig W, Strunk O, Westram R et al. (2004) ARB: a software environment for sequence data. Nucleic Acids Res 32: 1363-1371.
25. Moreno-Navarrete J, Ortega F, Serino M, Luche E, Waget A, Pardo G, Salvador J, Ricart W, Frühbeck G & Burcelin R (2011) Circulating lipopolysaccharide-binding protein (LBP) as a marker of obesity-related insulin resistance. Int J Obes 36: 1442-1449.
26. Musso G, Gambino R & Cassader M (2010) Obesity, diabetes, and gut microbiota. Diabetes Care 33: 2277-2284.
27. Musso G, Gambino R & Cassader M (2011) Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes. Annu Rev Med 62: 361-380.
28. Novitsky T (1998) Limitations of the Limulus amebocyte lysate test in demonstrating circulating lipopolysaccharides. Ann NY Acad Sci 851: 416-421.
29. Parnell JA & Reimer RA (2009) Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am J Clin Nutr 89: 1751-1759.
30. Santacruz A, Marcos A, Wärnberg J et al. (2009) Interplay between weight loss and gut microbiota composition in overweight adolescents. Obesity 17: 1906-1915.
31. Schloss PD & Handelsman J (2005) Introducing DOTUR, a computer program for defining operational taxonomic units and estimating species richness. Appl Environ Microbiol 71: 1501-1506.
32. Shoelson SE, Herrero L & Naaz A (2007) Obesity, inflammation, and insulin resistance. Gastroenterology 132: 2169-2180.
33. Sun L, Yu Z, Ye X et al. (2010) A marker of endotoxemia is associated with obesity and related metabolic disorders in apparently healthy Chinese. Diabetes Care 33: 1925-1932.
34. Tabák AG, Jokela M, Akbaraly TN, Brunner EJ, Kivim Ki M & Witte DR (2009) Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 373: 2215-2221.
35. Thurnham DI, Mburu AS, Mwaniki DL & Wagt AD (2005) Micronutrients in childhood and the influence of subclinical inflammation. Proc Nutr Soc 64: 502-509.
36. Van der Waaij D (1989) The ecology of the human intestine and its consequences for overgrowth by pathogens such as Clostridium difficile. Annu Rev Microbiol 43: 69-87.
37. Wallace TM, Levy JC & Matthews DR (2004) Use and abuse of HOMA modeling. Diabetes Care 27: 1487-1495.
38. Wellen KE & Hotamisligil GS (2005) Inflammation, stress, and diabetes. J Clin Invest 115: 1111-1119.
39. Zhang C, Zhang M, Wang S et al. (2010) Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice. ISME J 4: 232-241.
40. Zhang C, Zhang M, Pang X, Zhao Y, Wang L & Zhao L (2012) Structural resilience of the gut microbiota in adult mice under high-fat dietary perturbations. ISME J 6: 1848-1857.
41. Zhao L (2013) The gut microbiota and obesity: from correlation to causality. Nat Rev Microbiol 11: 639-647.